U.S. Markets open in 2 hrs 45 mins

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
135.81-0.57 (-0.42%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue108,97371,91464,538
Cost of Revenue5,5715,8079,136
Gross Profit103,40266,10755,402
Operating Expenses
Research Development21,22111,0059,747
Selling General and Administrative26,62124,37822,570
Non Recurring1,0321,0201,084
Total Operating Expenses59,51738,77835,776
Operating Income or Loss43,88527,32919,626
Income from Continuing Operations
Total Other Income/Expenses Net-23,74719,802-3,464
Earnings Before Interest and Taxes20,13847,13116,162
Interest Expense12,17811,8024,860
Income Before Tax7,96035,32911,302
Income Tax Expense10,327-192,115410
Minority Interest---1,910
Net Income From Continuing Ops-2,367227,44410,892
Non-recurring Events
Discontinued Operations731731731
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,636229,82412,024
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,636229,82412,024